1 year return (CAGR)
-35.40%
Kyntra Bio, Inc. Exchange (NASDAQ, USD)
KYNB
8.03
+0.06 (+0.75%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-31.36%
5 year return (CAGR)
-51.84%
10 year return (CAGR)
-32.89%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
32.51M
Price/Sales
7.04
Ent value
91.09M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
0.18
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.85 |
| Daily high | 8.06 |
| Daily low | 7.79 |
| Daily Volume | 24K |
| All-time high | 1681.25 |
| 1y analyst estimate | 39.00 |
| Beta | 1.04 |
| EPS (TTM) | 45.25 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KYNB | S&P500 | |
| Current price drop from All-time high | -99.52% | -2.19% |
| Highest price drop | -99.69% | -56.47% |
| Date of highest drop | 18 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -57.75% | -10.68% |
| Avg time to new high | 96 days | 12 days |
| Max time to new high | 2058 days | 1805 days |
News
